Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
Funding Opportunity RFA-HD-18-033 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viabl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
Funding Opportunity RFA-HD-18-034 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viabl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
Funding Opportunity PA-18-044 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
Funding Opportunity PA-18-043 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in the safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatment. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
Funding Opportunity PA-18-038 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
Funding Opportunity PA-18-092 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 2, 2017 Category: Research Source Type: funding

Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
Funding Opportunity PA-18-031 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 2, 2017 Category: Research Source Type: funding

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
Funding Opportunity PA-18-135 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2017 Category: Research Source Type: funding

Challenge Competition: Improving Remote Monitoring of Pregnancy
A prize competition to support the development and testing of low-cost, scalable technology-based innovations to improve the ability of prenatal care providers to monitor the health and well being of pregnant women remotely, especially women who live in rural and medically-underserved areas who have limited access to on-site prenatal care. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 25, 2017 Category: American Health Source Type: funding

Opioid Use Disorder in Pregnancy (R01)
Funding Opportunity RFA-HD-18-036 from the NIH Guide for Grants and Contracts. In this funding opportunity announcement (FOA), we invite prospective applicants to propose research addressing treatment of pregnant women with opioid use disorder and pharmacokinetic and pharmacodynamic studies of medications used for maternal treatment. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 25, 2017 Category: Research Source Type: funding

Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional)
The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative multipurpose prevention technologies (MPT) with rheological/biophysical properties and product user perceptions compatible with current long-acting reversible contraceptive (LARC) strategies (look, feel, effectiveness, safety and duration of action) for the dual purpose of preventing pregnancy and HIV infection in women. MPTs proposed for development must be dual indication and prevent pregnancy and HIV infection and have drug delivery systems (DDS) capable with sustained/extended release of both drugs. MPTs pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 12, 2017 Category: Research Source Type: funding

Pregnancy in Women with Disabilities (R01)
Funding Opportunity PA-17-452 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2017 Category: Research Source Type: funding

Pregnancy in Women with Disabilities (R03)
Funding Opportunity PA-17-451 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages small research project grants (R03) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2017 Category: Research Source Type: funding

Medication Assisted Treatment Delivery for Pregnant Women with Substance Use Disorders Involving Prescription Opioids and/or Heroin
Grants for large, randomized controlled trials or well-justified observational studies that compare the effectiveness for maternal and neonatal outcomes of different models for comprehensive Opioid Use Disorder treatment delivery for pregnant and post-partum women with different levels of addiction severity. Geographic coverage: Nationwide -- Patient-Centered Outcomes Research Institute (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 12, 2017 Category: American Health Source Type: funding

COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia
Funding Opportunity ID: 292933 Opportunity Number: CDC-RFA-GH15-16300301SUPP17 Opportunity Title: COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in LiberiaOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.318Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: ...
Source: Grants.gov - April 1, 2017 Category: Research Tags: Health Source Type: funding